(ECRP) Index Solutions - Index - Overview
Etf: Euro, Corporate, Bonds, SRI, Index
| Risk 5d forecast | |
|---|---|
| Volatility | 1.75% |
| Relative Tail Risk | 1.54% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.30 |
| Alpha | -0.88 |
| Character TTM | |
|---|---|
| Beta | -0.004 |
| Beta Downside | -0.016 |
| Drawdowns 3y | |
|---|---|
| Max DD | 1.90% |
| CAGR/Max DD | 2.78 |
Description: ECRP Index Solutions - Index January 08, 2026
The Amundi Index Euro AGG Corporate SRI Fund (PA:ECRP) is an ETF designed to replicate the Bloomberg Barclays MSCI Euro Corporate SRI Index, aiming to keep tracking error between the fund’s net asset value and the index performance as low as possible. Its benchmark is the Morningstar EZN Corp Bd GR EUR, which screens for European investment-grade corporate bonds that meet defined ESG criteria.
Key quantitative drivers (as of the latest data Q4 2025) include an average portfolio duration of roughly 5.2 years, a weighted average credit rating of A- (S&P) indicating investment-grade quality, and a current weighted-average yield near 3.1 % (EUR). The fund’s ESG tilt typically adds a modest premium of 10–15 bps over a conventional Euro corporate bond index, reflecting higher demand for sustainable issuances. Primary macro-economic influences are the European Central Bank’s policy rate trajectory, eurozone corporate refinancing cycles, and the expanding EU taxonomy-aligned bond market, which together shape credit spreads and issuance volumes.
For a deeper, data-driven assessment of how ECRP’s risk-adjusted returns compare to peers, you might explore the analytics platform ValueRay, which offers granular performance attribution and scenario analysis.
What is the price of ECRP shares?
Over the past week, the price has changed by +0.09%, over one month by +0.58%, over three months by +0.60% and over the past year by +2.93%.
Is ECRP a buy, sell or hold?
What are the forecasts/targets for the ECRP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 54.6 | 0.3% |
ECRP Fundamental Data Overview February 03, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 4.84b EUR (4.84b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 4.84b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 4.84b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 5.90% (E(4.84b)/V(4.84b) * Re(5.90%) + (debt-free company))
Discount Rate = 5.90% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)